Our Activities

Delivering More High-Quality Eisai Products to More Patients Around the World

January 26, 2012

Eisai recognizes our social responsibility, as a pharmaceutical company, to ensure a stable supply of high quality pharmaceutical products and their safe delivery to patients, as we are handling products which could directly affect people's lives. Based upon our sense of responsibility and high ethical standard, we established the General Policy on Product Quality and deliver high quality products around the world to those who need them.

In order to further develop our production and distribution activities from customer perspectives, we made a significant transformation – from being supply-oriented to demand-oriented, re-organizing and creating “Eisai Demand Chain Systems (EDCS)” in June, 2010. Our patient-focused approach as implemented in EDCS is also realized in the production, distribution, quality assurance and product security of our products for emerging and developing world markets.

Eisai has been very active in expanding its product logistics network in the emerging and developing countries for many years. Already in 1971 and 1974, we established manufacturing plants in Indonesia and Taiwan, respectively, and transferred technologies there from Japan, in order to supply locally-manufactured high quality products for patients. In countries where local production by Eisai is difficult, we have been supplying high quality products in a stable manner by exporting finished products from Japan or by utilizing our own manufacturing plants in other developing and emerging countries or contract manufacturing plants. Furthermore, our current mid-term strategic plan, “HAYABUSA”, which started in fiscal year 2011, makes clear that business expansion in emerging country markets is of great importance for Eisai. Eisai therefore aims to further enhance its globalization and expand its manufacturing and distribution networks in emerging and developing markets.

About Mid-term Strategic Plan “HAYABUSA”:
See Fiscal Year 2011 Annual Report (pages 08 - 29)

• http://www.eisai.com/pdf/eannual/epdf2011an.pdf

At present, Eisai has manufacturing facilities in the USA, UK, China, India, Taiwan and Indonesia, as well as in Japan where four sites are located. Each facility possesses its own strategic function based upon its own strength. For stable supply of high quality products anywhere in the world, these facilities are utilized in a flexible manner. This approach enables realization of our “affordable pricing” strategy where we aim to provide our products to patients at prices affordable to them.

Through manufacturing, distribution and quality assurance of medicinal products, Eisai is committed to contribute to better access to medicines around the world. We aim to understand the varied needs of patients and ensure stable supply of high quality products with affordable pricing via our “demand chain”, or production and distribution networks, which are optimized for each region.